Position in LUNG
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$19,341
+$19,338 QoQ
Shares Held
14,878
+495833.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 108 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LUNG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $49,649,548 across 86 Medical Devices names. LUNG ranks #63 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
144,198 | $13,084,526 | |
| 2 | SYK |
Stryker Corp
|
17,775 | $5,596,281 | |
| 3 | MDT |
Medtronic plc
|
60,057 | $4,698,259 | |
| 4 | TXG |
10x Genomics, Inc.
|
90,139 | $3,455,929 | |
| 5 | BSX |
Boston Scientific Corp
|
77,337 | $3,300,743 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
34,980 | $3,011,428 | |
| 7 | BRKR |
Bruker Corp
|
49,085 | $2,953,935 | |
| 8 | PODD |
Insulet Corp
|
14,292 | $2,175,957 |
All Filings in LUNG
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,341 | 14,878 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3 | 3 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $2,300 | 1,420 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $713 | 106 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $719 | 106 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $770 | 93 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $589 | 93 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||